Lysyl oxidase like-2 in fibrosis and cardiovascular disease
American Journal of Physiology-Cell Physiology · 01.09.2023 · 325 (3) · C694-C707
DOI: 10.1152/ajpcell.00176.2023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.09.2023. Verfasst von Alan Poe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, United States. Hauptthemen laut MEDLINE: Protein-Lysine 6-Oxidase, Cardiovascular Diseases. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, American Heart Association, HHS | NIH | National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Fibrosis is an important and essential reparative response to injury that, if left uncontrolled, results in the excessive synthesis, deposition, remodeling, and stiffening of the extracellular matrix, which is deleterious to organ function. Thus, the sustained activation of enzymes that catalyze matrix remodeling and cross linking is a fundamental step in the pathology of fibrotic diseases. Recent studies have implicated the amine oxidase lysyl oxidase like-2 (LOXL2) in this process and established significantly elevated expression of LOXL2 as a key component of profibrotic conditions in several organ systems. Understanding the relationship between LOXL2 and fibrosis as well as the mechanisms behind these relationships can offer significant insights for developing novel therapies. Here, we summarize the key findings that demonstrate the link between LOXL2 and fibrosis and inflammation, examine current therapeutics targeting LOXL2 for the treatment of fibrosis, and discuss future directions for experiments and biomedical engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, United States.
- Department of Anesthesiology and CCM, Johns Hopkins University, Baltimore, Maryland, United States.
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, United States.
ORCID-Profile: Lakshmi Santhanam
Förderung
- NHLBI NIH HHS
- American Heart Association
- HHS | NIH | National Heart, Lung, and Blood Institute
Zitieren
APA
Poe, A., Martinez Yus, M., Wang, H., & Santhanam, L. (2023). Lysyl oxidase like-2 in fibrosis and cardiovascular disease. American Journal of Physiology-Cell Physiology, 325(3), C694-C707. https://doi.org/10.1152/ajpcell.00176.2023
Vancouver
Poe A, Martinez Yus M, Wang H, Santhanam L. Lysyl oxidase like-2 in fibrosis and cardiovascular disease. American Journal of Physiology-Cell Physiology. 2023;325(3):C694-C707. doi:10.1152/ajpcell.00176.2023
BibTeX
@article{Poe2023,
author = {Poe, Alan and Martinez Yus, Marta and Wang, Huilei and Santhanam, Lakshmi},
title = {Lysyl oxidase like-2 in fibrosis and cardiovascular disease},
journal = {American Journal of Physiology-Cell Physiology},
year = {2023},
volume = {325},
number = {3},
pages = {C694--C707},
doi = {10.1152/ajpcell.00176.2023}
}
EUVIMED